Seelos Therapeutics, Inc.
NASDAQ: SEEL0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Raj Mehra
- Employees
- 8
- Headquarters
- New York City, United States
- IPO year
- 1999
- Market cap
- $215.0K
- Website
- https://seelostherapeutics.com
Loading SEEL…
Loading profile data…Frequently asked questions about SEEL
What does Seelos Therapeutics, Inc. (SEEL) do?
Seelos Therapeutics, Inc. is a biopharmaceutical firm operating at the clinical stage, dedicated to the discovery, development, and eventual commercialization of innovative therapies. These treatments primarily target central nervous system (CNS), respiratory, and various other medical conditions. The company's pipeline includes several key clin...
Where does SEEL trade?
Seelos Therapeutics, Inc. (SEEL) trades on the NASDAQ Capital Market.
What sector is SEEL in?
Seelos Therapeutics, Inc. (SEEL) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Seelos Therapeutics, Inc.?
Raj Mehra is the chief executive officer of Seelos Therapeutics, Inc. (SEEL).
Where is Seelos Therapeutics, Inc. headquartered?
Seelos Therapeutics, Inc. is headquartered in United States.
Does SEEL pay a dividend?
Seelos Therapeutics, Inc. (SEEL) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SEEL go public?
Seelos Therapeutics, Inc. (SEEL) completed its initial public offering in 1999.